Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK

详细信息    查看全文

• 作者：Keitaro Yamane (1)
  Masatoshi Jinnin (1)
  Tomomi Etoh (1)
  Yuki Kobayashi (1)
  Naoki Shimozono (1)
  Satoshi Fukushima (1)
  Shinichi Masuguchi (1)
  Keishi Maruo (1)
  Yuji Inoue (1)
  Tsuyoshi Ishihara (1)
  Jun Aoi (1) (2)
  Yuichi Oike (2)
  Hironobu Ihn (1)
  
• 关键词：Cancer ; Skin ; RNA
• 刊名：Journal of Molecular Medicine
• 出版年：2013
• 出版时间：January 2013
• 年：2013
• 卷：91
• 期：1
• 页码：69-81
• 全文大小：824KB
• 参考文献：1. Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344:975鈥?83 CrossRef
  2. Pfaff D, Philippova M, Buechner S, Maslova K, Mathys T, Erne P, Resink T (2010) T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo. Br J Dermatol 163:353鈥?63 CrossRef
  3. Wu X, Nguyen B, Dziunycz P, Chang S, Brooks Y, Lefort K, Hofbauer G, Dotto G (2010) Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 465:368鈥?72 CrossRef
  4. Ganapathy A, Paterson IC, Prime SS, Eveson JW, Pring M, Price N, Threadgold SP, Davies M (2010) TGF-尾 inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1. Cancer Lett 298:107鈥?18 CrossRef
  5. Kubo M, Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K (2001) Differential expression of transforming growth factor-beta receptors in squamous cell carcinoma. Br J Dermatol 145:840鈥?42 CrossRef
  6. Lu ZH, Shvartsman MB, Lee AY, Shao JM, Murray MM, Kladney RD, Fan D, Krajewski S, Chiang GG, Mills GB et al (2010) Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis. Cancer Res 70:3287鈥?298 CrossRef
  7. Ke H, Harris R, Coloff JL, Jin JY, Leshin B, Miliani de Marval P, Tao S, Rathmell JC, Hall RP, Zhang JY (2010) The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia. Cancer Res 70:3080鈥?088 CrossRef
  8. Hida Y, Kubo Y, Arase S (2009) Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours. Br J Dermatol 160:1258鈥?263 CrossRef
  9. Ayli EE, Li W, Brown TT, Witkiewicz A, Elenitsas R, Seykora JT (2008) Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders. J Cutan Pathol 35:273鈥?77 CrossRef
  10. Zhao L, Li W, Marshall C, Griffin T, Hanson M, Hick R, Dentchev T, Williams E, Werth A, Miller C et al (2009) Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53. Cancer Res 69:9439鈥?447 CrossRef
  11. Kubo Y, Urano Y, Yoshimoto K, Iwahana H, Fukuhara K, Arase S, Itakura M (1994) p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. J Investig Dermatol 102:440鈥?44 CrossRef
  12. Murao K, Kubo Y, Ohtani N, Hara E, Arase S (2006) Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Dermatol 155:999鈥?005 CrossRef
  13. Smith L, Watson M, O鈥橩ane S, Drew P, Lind M, Cawkwell L (2006) The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther 5:2115鈥?120 CrossRef
  14. Kopf E, Shnitzer D, Zharhary D (2005) Panorama Ab Microarray Cell Signaling kit: a unique tool for protein expression analysis. Proteomics 5:2412鈥?416 CrossRef
  15. Moriya C, Jinnin M, Yamane K, Maruo K, Muchemwa FC, Igata T, Makino T, Fukushima S, Ihn H (2011) Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-未 in normal human dermal fibroblasts. J Investig Dermatol 131:655鈥?61 CrossRef
  16. Makino T, Jinnin M, Muchemwa FC, Fukushima S, Kogushi-Nishi H, Moriya C, Igata T, Fujisawa A, Johno T, Ihn H (2010) Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br J Dermatol 162:717鈥?23 CrossRef
  17. Nakashima T, Jinnin M, Etoh T, Fukushima S, Masuguchi S, Maruo K, Inoue Y, Ishihara T, Ihn H (2010) Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One 5:e14334 CrossRef
  18. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50:298鈥?01 CrossRef
  19. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N et al (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148 CrossRef
  20. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O鈥橞riant KC, Allen A et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513鈥?0518 CrossRef
  21. Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR (2008) Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14:1236鈥?246 CrossRef
  22. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089鈥?099 CrossRef
  23. Handra-Luca A, Bilal H, Bertrand JC, Fouret P (2003) Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. Am J Pathol 163:957鈥?67 CrossRef
  24. Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL, Pescovitz OH (2004) Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 18:2570鈥?582 CrossRef
  25. Mishima K, Inoue K, Hayashi Y (2002) Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol 38:468鈥?74 CrossRef
  26. Kanemaru H, Fukushima S, Yamashita J, Honda N, Oyama R, Kakimoto A, Masuguchi S, Ishihara T, Inoue Y, Jinnin M et al (2011) The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 61:187鈥?93 CrossRef
  27. Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N (2010) RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464:427鈥?30 CrossRef
  28. Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G et al (2010) RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464:431鈥?35 CrossRef
  29. Li H, Bian C, Liao L, Li J, Zhao R (2010) miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat 126:565鈥?75 CrossRef
  30. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67:2456鈥?468 CrossRef
  31. Cortez MA, Calin GA (2009) MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9:703鈥?11 CrossRef
  32. Yagi H, Danno K, Maruguchi Y, Yamamoto M, Imamura S (1987) Significance of squamous cell carcinoma (SCC)-related antigens in cutaneous SCC. A preliminary report. Arch Dermatol 123:902鈥?06 CrossRef
  33. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S (2010) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5:e13735 CrossRef
  34. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, St枚ppler H, Simko J, Hilton JF, Carroll P, Blelloch R (2011) Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res 71:550鈥?60 CrossRef
  35. Silva J, Garc铆a V, Zaballos A, Provencio M, Lombard铆a L, Almonacid L, Garc铆a JM, Dom铆nguez G, Pe帽a C, Diaz R et al (2011) Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 37:617鈥?23 CrossRef
  
• 作者单位：Keitaro Yamane (1)
  Masatoshi Jinnin (1)
  Tomomi Etoh (1)
  Yuki Kobayashi (1)
  Naoki Shimozono (1)
  Satoshi Fukushima (1)
  Shinichi Masuguchi (1)
  Keishi Maruo (1)
  Yuji Inoue (1)
  Tsuyoshi Ishihara (1)
  Jun Aoi (1) (2)
  Yuichi Oike (2)
  Hironobu Ihn (1)
  
  1. Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
  2. Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
  
• ISSN：1432-1440

文摘

Squamous cell carcinoma (SCC) is one of the most common skin cancers. Because its potential to recur and metastasize leads to a poor prognosis and significant mortality, it is necessary to develop new early diagnostic tools and new therapeutic approaches. In this study, we found protein levels of ERK1 and ERK2 were increased in SCC cell lines without changing mRNA levels and that ERK1/2 mediates abnormal cell proliferation in these cells. Then, mechanisms underlying the overexpression of ERK1/2 in SCC were investigated focusing on microRNA. We found that miR-214 is the regulator of ERK1, whereas ERK2 is regulated by miR-124 and miR-214. Expression of miR-124 and miR-214 was significantly down-regulated in SCC in vitro and in vivo. Treatment with 5-aza-deoxycytidine and trichostatin A synergistically recovered the miR-124/-214 down-regulation in SCC cell line. However, bisulphite sequencing revealed the methylation status of miR-124/-214 promoter was not increased in the SCC cell line and tumor tissue. Taken together, the down-regulation of miR-124/-214 in SCC is most likely caused, at least in part, by hypermethylation of other promoter regions rather than the miR-124/-214 promoter. Supplementation of these microRNAs in the SCC cell line reduced the abnormal cell proliferation by normalizing ERK1/2 levels. Additionally, serum concentration of miR-124 was correlated with miR-124 expression levels in the tumor tissues and inversely correlated with tumor progression. On the other hand, miR-214 was not detected in the serum. Investigation of the regulatory mechanisms of keratinocyte proliferation by microRNA may lead to develop new biomarkers and treatments using microRNA.